The 2021 Medtech Contract Manufacturing Report

Download

Global Coronary Angiography Devices Market

10 Pages | 14 Exhibits | Forecasts Through 2024
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now
Talk to Sales

Overview

This report from Life Science Intelligence provides the latest market data for the Global Coronary Angiography Devices Market. Information covered by this report includes:

·        unit volumes & pricing forecast from 2019-2024

·        analyses of the leading companies, and

·        global market share analysis.

The global market for coronary angiography devices is expected to reach an estimated $366.6 million in 2020 and is projected to increase at a CAGR (2020-2024) of 9.9%. Product segments covered by this report include catheters and guidewires for use in coronary angiography procedures.

This report covers the impact of COVID-19 on the coronary angiography devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Boston Scientific, Cook Medical, Medtronic, Abbott, Terumo, and others. The report provides insights into trends, drivers, and limiters of the coronary angiography devices market, as well as highlights potential opportunities.

Cardiovascular diseases are the number one cause of death in the world and around 17.9 million people worldwide die of it. Coronary heart disease is the most common type of heart disease and claims more than 14 million lives. Coronary angiography devices are used to diagnose and treat coronary heart diseases. The devices include catheters and guidewires used in coronary interventions.

The volume of coronary angiography procedures was severely impacted by the COVID-19 pandemic. While critically ill patients requiring more intensive cardiovascular interventions were less harshly impacted by COVID-19, less severe cases of cardiovascular disease requiring diagnosis and intervention were likely to be postponed to free up healthcare resources and prevent the spread of the virus to more at-risk patient populations. Interventional cardiology procedures are expected to recover to pre-COVID-19 levels in 2021.

Companies Covered

  • Abbott Vascular
  • Angiodynamics
  • B Braun
  • Boston Scientific
  • Cook
  • Cordis Cardinal Health
  • Medtronic
  • Merit Medical
  • Teleflex
  • Terumo Cardiovascular
  • Volcano/Philips Medical

 

Our Clients